A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer
Objectives Identification of endometrial cancers (EC) with mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) is essential for Lynch syndrome screening and treatment stratification. We aimed to assess the utility of immunohistochemistry (IHC) staining for MMR protein expres...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2023-08-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/15920.pdf |
| _version_ | 1827606792333426688 |
|---|---|
| author | Cheng Wang Wei Kuang Jing Zeng Yang Ren Qianqi Liu Huanxin Sun Min Feng Dongni Liang |
| author_facet | Cheng Wang Wei Kuang Jing Zeng Yang Ren Qianqi Liu Huanxin Sun Min Feng Dongni Liang |
| author_sort | Cheng Wang |
| collection | DOAJ |
| description | Objectives Identification of endometrial cancers (EC) with mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) is essential for Lynch syndrome screening and treatment stratification. We aimed to assess the utility of immunohistochemistry (IHC) staining for MMR protein expression and polymerase chain reaction (PCR)-based MSI assays in EC and the correlation between MMR/MSI status and various clinicopathological parameters. Methods We reviewed the clinical and pathological information of 333 patients with EC. MMR protein expression was assessed as retained or lost to determine MMR status by IHC staining, and MSI status was identified by PCR capillary electrophoresis (PCR-CE) testing with a National Cancer Institute (NCI) panel. The correlation of MMR/MSI status with clinicopathological features was determined by statistical analysis. Discrepant results were further analyzed using an alternative PCR-CE MSI (Promega panel) method, MLH1 promoter methylation assays, and next-generation sequencing (NGS). Results Among the EC patients, the overall percentage of dMMR was 25.2%, and the overall percentage of MSI-H was 24%. Among the dMMR patients, 50 (59.5%) showed loss of MLH1 and PMS2 expression, 19 (22.6%) loss of MSH2 and MSH6 expression, and seven (8.3%) and eight (9.5%) loss of PMS2 and MSH6 expression, respectively. The dMMR subgroup was significantly younger than the pMMR subgroup, especially for <60-years-old patients (p = 0.038). In addition, we identified a strong correlation between MMR/MSI status and high-grade endometrioid or nonendometrioid components (p = 0.004 or p = 0.003). IHC staining and PCR-CE assay results showed a high level of overall concordance (98.8%, Cohen’s κ = 0.98). Four patients were found to have dMRR/MSS in both examinations. We reanalyzed them with additional methods. One case showed MLH1 promotor methylation, and the other three cases harbored MSH6 germline pathogenic variations. One of the cases with MSH6 deficiency was reanalyzed as MSI-H by alternative PCR-CE assay or NGS testing. Conclusions This study indicates that the combined use of MMR-IHC and PCR-CE MSI analyses may effectively avoid misdiagnoses of EC patients with dMMR/MSI-H. However, use of PCR-CE alone to evaluate MMR/MSI status may lead to missed diagnosis, especially for EC patients with MSH6 deficiency and presenting MSS. |
| first_indexed | 2024-03-09T06:44:26Z |
| format | Article |
| id | doaj.art-8165b0e8b2134958a3add340d190d5f8 |
| institution | Directory Open Access Journal |
| issn | 2167-8359 |
| language | English |
| last_indexed | 2024-03-09T06:44:26Z |
| publishDate | 2023-08-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj.art-8165b0e8b2134958a3add340d190d5f82023-12-03T10:39:05ZengPeerJ Inc.PeerJ2167-83592023-08-0111e1592010.7717/peerj.15920A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancerCheng Wang0Wei Kuang1Jing Zeng2Yang Ren3Qianqi Liu4Huanxin Sun5Min Feng6Dongni Liang7Department of Pathology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Pathology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Pathology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Pathology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Pathology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaDepartment of Pathology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, ChinaObjectives Identification of endometrial cancers (EC) with mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) is essential for Lynch syndrome screening and treatment stratification. We aimed to assess the utility of immunohistochemistry (IHC) staining for MMR protein expression and polymerase chain reaction (PCR)-based MSI assays in EC and the correlation between MMR/MSI status and various clinicopathological parameters. Methods We reviewed the clinical and pathological information of 333 patients with EC. MMR protein expression was assessed as retained or lost to determine MMR status by IHC staining, and MSI status was identified by PCR capillary electrophoresis (PCR-CE) testing with a National Cancer Institute (NCI) panel. The correlation of MMR/MSI status with clinicopathological features was determined by statistical analysis. Discrepant results were further analyzed using an alternative PCR-CE MSI (Promega panel) method, MLH1 promoter methylation assays, and next-generation sequencing (NGS). Results Among the EC patients, the overall percentage of dMMR was 25.2%, and the overall percentage of MSI-H was 24%. Among the dMMR patients, 50 (59.5%) showed loss of MLH1 and PMS2 expression, 19 (22.6%) loss of MSH2 and MSH6 expression, and seven (8.3%) and eight (9.5%) loss of PMS2 and MSH6 expression, respectively. The dMMR subgroup was significantly younger than the pMMR subgroup, especially for <60-years-old patients (p = 0.038). In addition, we identified a strong correlation between MMR/MSI status and high-grade endometrioid or nonendometrioid components (p = 0.004 or p = 0.003). IHC staining and PCR-CE assay results showed a high level of overall concordance (98.8%, Cohen’s κ = 0.98). Four patients were found to have dMRR/MSS in both examinations. We reanalyzed them with additional methods. One case showed MLH1 promotor methylation, and the other three cases harbored MSH6 germline pathogenic variations. One of the cases with MSH6 deficiency was reanalyzed as MSI-H by alternative PCR-CE assay or NGS testing. Conclusions This study indicates that the combined use of MMR-IHC and PCR-CE MSI analyses may effectively avoid misdiagnoses of EC patients with dMMR/MSI-H. However, use of PCR-CE alone to evaluate MMR/MSI status may lead to missed diagnosis, especially for EC patients with MSH6 deficiency and presenting MSS.https://peerj.com/articles/15920.pdfMismatch repair deficiency (dMMR)Microsatellite instability-high (MSI-H)Immunohistochemistry (IHC)Polymerase chain reaction (PCR)Endometrial cancers (EC) |
| spellingShingle | Cheng Wang Wei Kuang Jing Zeng Yang Ren Qianqi Liu Huanxin Sun Min Feng Dongni Liang A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer PeerJ Mismatch repair deficiency (dMMR) Microsatellite instability-high (MSI-H) Immunohistochemistry (IHC) Polymerase chain reaction (PCR) Endometrial cancers (EC) |
| title | A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer |
| title_full | A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer |
| title_fullStr | A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer |
| title_full_unstemmed | A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer |
| title_short | A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer |
| title_sort | retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer |
| topic | Mismatch repair deficiency (dMMR) Microsatellite instability-high (MSI-H) Immunohistochemistry (IHC) Polymerase chain reaction (PCR) Endometrial cancers (EC) |
| url | https://peerj.com/articles/15920.pdf |
| work_keys_str_mv | AT chengwang aretrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT weikuang aretrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT jingzeng aretrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT yangren aretrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT qianqiliu aretrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT huanxinsun aretrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT minfeng aretrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT dongniliang aretrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT chengwang retrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT weikuang retrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT jingzeng retrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT yangren retrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT qianqiliu retrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT huanxinsun retrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT minfeng retrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer AT dongniliang retrospectivestudyofconsistencybetweenimmunohistochemistryandpolymerasechainreactionofmicrosatelliteinstabilityinendometrialcancer |